Tracy MacNeal is a chemical engineer turned healthcare executive who serves as President and CEO of Materna Medical, a women's health technology company in Mountain View, California. With more than 25 years across pharmaceuticals, diagnostics, digital health and medical devices, and six transactions to her name, she has built a career on commercializing hard-to-define products and opening markets that others overlook. She sits on the board of AdvaMed and chairs its Women's Executive Network, and she is known for pairing engineering rigor with a storyteller's instinct for building trust with clinicians, investors and customers.

Adrianne Nickerson is the co-founder and CEO of Oula, a New York maternity company that fuses midwives, OB-GYNs and technology into one hybrid clinic built to give pregnant patients a calmer, more personal, evidence-based birth experience. A Columbia biology grad with a Harvard master's in global health, she decided she could help patients more by not becoming a doctor - and instead builds the systems doctors and midwives work inside. She co-founded Oula in 2019, opened it while pregnant alongside two pregnant co-executives, and has raised tens of millions to expand care that reduces unnecessary C-sections and centers patient voices.
Mylene Yao is co-founder, director, and CEO of Univfy, a Los Altos-based healthcare AI company that builds personalized IVF success prediction models. A board-certified OB/GYN trained at the University of Toronto, McGill, and Harvard, she was a Stanford faculty member running an NIH-funded embryo development lab before spinning her prediction research out with statistician Wing H. Wong. Univfy's models tell patients their individual odds of having a baby with IVF, and pair the prediction with financing so more people can actually pursue treatment.
Neil P. Ray, MD is a board-certified pediatric anesthesiologist who traded the operating room for a startup. As founder and CEO of Raydiant Oximetry, he is building Lumerah, a non-invasive fetal pulse oximeter that reads a baby's oxygen levels through the mother's abdomen, and Daisy, a surgical device to prevent postpartum hemorrhage. His goal: retire a 50-year-old fetal monitor he calls no better than a coin toss, and cut the number of unnecessary C-sections that follow from it.
Catherine Magee is the co-founder and CEO of Playground, a sexual wellness brand she launched in 2022 with product developer Sandy Vukovic and pop star Christina Aguilera. After more than 15 years building aspirational beauty brands at companies like bareMinerals, Buxom, Rodan + Fields and theBalm Cosmetics, Magee set out to give intimate care the same skincare-grade performance and cosmetic-level joy that the beauty aisle had long enjoyed. Under her leadership Playground reached Target, Urban Outfitters and Amazon, raised roughly $2 million in seed funding, generated billions of social impressions, and landed Magee on Inc.'s 2024 Female Founders 250 list.
Roberta Sotomaior is the co-founder and CEO of Bloom Care, a Sao Paulo digital health platform for women and families that she built after walking away from a career in international diplomacy. She spent roughly six years studying conflict resolution in Boston, decided prevention beat firefighting, and turned that conviction into a B2B2C company now embedded as a corporate benefit at hundreds of Brazilian employers including Natura, Sanofi and SulAmerica. She raised a R$3M pre-seed in 2021, drew angel checks from the presidents and ex-CEOs of Novartis and Gympass, and made CB Insights' global list of promising digital health startups as the only one founded entirely by women.
Sarah Oreck is a Columbia-trained reproductive psychiatrist who co-founded and runs Mavida Health, a virtual platform built around a simple, long-ignored idea: women's mental health and their hormones are inseparable. From a private LA practice she scaled a clinical care model across four states - covering PMDD, fertility, pregnancy, postpartum, and menopause - through individual, group, and couples therapy plus medication management. In June 2026 Mavida was acquired by WPS, with Oreck staying on as co-founder.
Sujay Suresh Kumar is the cofounder and co-CEO of Lilu, a New York women's health hardware company building smart wearable tech for new mothers. An electrical engineer trained at the University of Pennsylvania, he designed circuits for CERN's ATLAS experiment, helped launch 4G in India at Reliance Jio, and spent two years on factory floors in Shenzhen turning a robotics-class side project into shipping products. He was named to Forbes 30 Under 30 in 2022.
Tara Raffi is the founder and CEO of Almond ObGyn, a venture-backed, tech-enabled women's health practice she co-founded with Carly Allen in 2021. A former McKinsey consultant who built the firm's $50M internal tech incubator and was an early operations and marketing hire at the location-data company Factual, she started Almond after years of frustrating personal experiences trying to book gynecological care. Backed by Y Combinator (S22), True Ventures and others with a $7M seed round, Almond pitches itself as 'One Medical for women's health,' combining in-person LA clinics with telehealth. Raffi and Allen were named to Inc.'s 2024 Female Founders 250 list.
Amelia Degenkolb is the CEO and co-founder of Novocuff, a Mountain View medical device company building the Cervical Control System, a device designed to stabilize the cervix, retain amniotic fluid and prolong pregnancies threatened by preterm premature rupture of membranes. A biomedical engineer who spent seven years as the first employee and lead engineer at Alydia Health, she helped bring the Jada System for postpartum hemorrhage to market before that company's $240M acquisition by Organon. In July 2024 she raised an oversubscribed $26M Series A to fund a U.S. pivotal trial aimed at reducing preterm births, the leading cause of infant mortality worldwide.
Anne Fulenwider spent 25 years turning sentences into magazine covers, capped by eight years as editor-in-chief of Marie Claire. Then she walked away from the masthead to co-found Alloy Women's Health, a digital company that connects women in perimenopause and menopause to menopause-trained physicians and doctor-prescribed treatment delivered to the door. She runs it as co-CEO alongside Monica Molenaar, applying an editor's instinct for storytelling to one of medicine's most overlooked subjects.
Connie Lehman is a radiologist who spent three decades reading mammograms and decided the picture could tell a different story. As founder and CEO of Boston-based Clairity, she built the first FDA-authorized AI platform that reads a routine screening mammogram and estimates a woman's five-year risk of developing breast cancer, spotting tissue patterns invisible to the human eye. A Professor of Radiology at Harvard Medical School with more than 300 peer-reviewed publications, she left a celebrated academic career to commercialize the idea that imaging should predict cancer, not just find it. TIME named her to its 2026 TIME100 Health list and Forbes to its 50 Over 50: Innovation list.
Priyanka Jain is the co-founder and CEO of Evvy, a New York precision women's health company building the largest dataset on the vaginal microbiome. A former Head of Product at AI hiring startup pymetrics and a Stanford Mayfield Fellow, she pivoted from making hiring fairer to closing the gender health gap. Under her leadership Evvy launched the first CLIA/CAP/CLEP-certified at-home metagenomic vaginal microbiome test, raised a $14M Series A, and landed Jain on Forbes 30 Under 30 and Inc.'s Female Founders lists.
Frédérique Dame is a General Partner at GV (Google Ventures), where she leads investments in consumer technology, life sciences, and AI. A French immigrant who moved to Silicon Valley at 24, she built her career as a product and engineering leader at Yahoo!, Photobucket, SmugMug, and Uber — where she helped scale the company from 80 employees to 7,000+ across 68 countries. At GV she co-leads the Women's Health investment team and has backed companies including Midi Health, Found, Allara, Oula Health, and TMRW. She serves on the board of Les Mills International and previously on Ubisoft's board, and was named to Rock Health's Top 50 in Digital Health.
Eric Dy, PhD is the co-founder and CEO of Bloomlife, a San Francisco-based women's health company building connected care solutions for maternal and fetal monitoring. A biomedical engineer by training (Cornell BSc, UCLA MSc and PhD), Dy spent four years at IMEC - Europe's leading R&D institute - establishing 17 partnerships worth $25M+ in revenue before launching Bloomlife in 2014. His personal experience watching his wife navigate a high-risk pregnancy - gestational diabetes, preeclampsia, placental complications, preterm labor, and a son who spent his first month in the NICU - drove him to attack the most underserved gap in American healthcare. Bloomlife's FDA-cleared MFM-Pro wearable lets high-risk pregnant patients be monitored at home, replacing the endless clinic visits that define the current broken system. The company raised a $12.2M Series A in September 2024 and has secured reimbursement across 18 payers.
Kara Egan is the co-founder and CEO of Teal Health, the San Francisco-based company behind the Teal Wand - the first and only FDA-authorized at-home self-collection device for cervical cancer screening in the United States. A Stanford engineer-turned-Wharton MBA, Kara spent years as a venture capital investor at Emergence Capital and .406 Ventures before betting on a product she believed could remake an 80-year-old medical process. Backed by $23M from investors including Emerson Collective, Serena Ventures, and Forerunner, Teal Health has rapidly expanded nationwide with a device that studies show is just as accurate as in-clinic screening and preferred by 94% of women who tried it.
Dr. Sophia Yen, MD, MPH is the CEO and Co-Founder of Pandia Health, the only women-founded, women-led, doctor-founded, physician-led birth control and menopause telemedicine and medication delivery service in the United States. A Clinical Associate Professor of Pediatrics at Stanford Medical School with 20+ years in medicine, she brings MIT engineering instincts, UCSF medical training, and UC Berkeley public health expertise to the problem of making prescription contraceptives and hormonal care radically more accessible for women. She co-founded SheHeroes.org to inspire girls in STEM and has been a nationally recognized voice on reproductive rights, menstrual equity, and women's health innovation.
Sylvia Kang is the CEO and co-founder of Mira (Miracare), the company behind the world's first FDA and CE-registered comprehensive at-home hormone monitoring platform. A former concert pianist who pivoted to biomedical engineering, she built Mira from her kitchen table into a 140-person company with 200,000+ users worldwide and over 50,000 women helped to conceive naturally. Named to Inc. Magazine's 2024 Female Founders 250 list and Femtech World's Leader of the Year, Kang holds an MS in Biomedical Engineering from Columbia and an MBA from Cornell, and used her own product to conceive after age 35.